Jagsonpal Pharmaceuticals Limited — Important, 21-04-2025: Updates

The Nomination and Remuneration Committee of Jagsonpal Pharmaceuticals Limited has allotted 39,850 equity shares under the Employee Stock Option Plan, 2022, to eligible employees upon exercising their vested options. Following this issuance, the company's paid-up share capital has increased from ₹13,27,97,260 to ₹13,28,76,960, translating to an increase in the number of equity shares from 6,63,98,630 to 6,64,38,480. This move reflects the company's commitment to employee empowerment and retention, creating a positive outlook for talent retention and motivation within the workforce. Keep an eye on how this development may influence organizational morale and performance.